Cargando…
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
BACKGROUND: Most mutations in melanoma affect one critical amino acid on BRAF gene, resulting in the V600E substitution. Patient management is often based on the use of specific inhibitors targeting this mutation. METHODS: DNA and RNA mutation status was assessed in 15 melanoma cell lines by Sanger...
Autores principales: | Al Hashmi, Muna, Sastry, Konduru S., Silcock, Lee, Chouchane, Lotfi, Mattei, Valentina, James, Nicola, Mathew, Rebecca, Bedognetti, Davide, De Giorgi, Valeria, Murtas, Daniela, Liu, Wei, Chouchane, Aouatef, Temanni, Ramzi, Seliger, Barbara, Wang, Ena, Marincola, Francesco M., Tomei, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216681/ https://www.ncbi.nlm.nih.gov/pubmed/32393282 http://dx.doi.org/10.1186/s12967-020-02350-8 |
Ejemplares similares
-
Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling
por: Sastry, Konduru S, et al.
Publicado: (2017) -
The immune‐related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2014) -
The immune-related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2015) -
Monoallelic expression in melanoma
por: Silcock, Lee, et al.
Publicado: (2019) -
Temple-Baraitser Syndrome and Zimmermann-Laband Syndrome: one clinical entity?
por: Mégarbané, André, et al.
Publicado: (2016)